Coxiella burnetii is the Gram-negative obligate intracellular pathogen that causes Q fever, a condition which presents as either acute or chronic disease (BOX 1). Phylogenetic analyses have shown that isolates causing acute and chronic disease fall into distinct groups, supporting the prediction that there are genetically distinct C. burnetii pathotypes (BOX 2). As an intracellular pathogen, this organism has evolved a range of mechanisms to invade and survive within host cells. C. burnetii has a trop ism for professional phagocytes and invades such cells using classic phagocytic mechanisms that rely on specific receptor-ligand interactions 1 . Inside the host cell, invading bacterial pathogens typically subvert phagosomal matur ation using a variety of mechanisms 2 . However, C. burnetii does not follow this paradigm, but instead actively directs the maturation of a phagolysosome-like compartment known as the Coxiella-containing vacuole (CCV) [3] [4] [5] . C. burnetii is readily transmitted between hosts and environmental reservoirs, a characteristic that is partially attributed to the ability of the bacterium to survive in the environment for long periods of time. The environmental stability of the organism seems to be linked to its ability to transition between distinct developmental stages. Small cell variants (SCVs) are metabolically inactive and resistant to numerous harsh environmental conditions. The switch from SCV to large cell variant (LCV) occurs after the invasion of host cells and during acidification of the phagosome, which triggers C. burnetii to become metabolically active 6, 7 . Until recently, the only characterized virulence factor of C. burnetii was lipopolysaccharide (LPS), which was identified through the observation that serial passage in a non-immunologically competent host results in the transition from a smooth to a rough phenotype and the loss of virulence 8 . Virulent smooth cell variants contain LPS with a complete O antigen and are referred to as phase I organisms, whereas avirulent rough cell variants lack the terminal O antigen sugars and are referred to as phase II organisms. The identification and characterization of other virulence factors has been facilitated by two recent advances: the development of axenic culture media and improvements in the tools available for genetic manipulation (BOX 3).
.
Inside the host cell, invading bacterial pathogens typically subvert phagosomal matur ation using a variety of mechanisms 2 . However, C. burnetii does not follow this paradigm, but instead actively directs the maturation of a phagolysosome-like compartment known as the Coxiella-containing vacuole (CCV) [3] [4] [5] . C. burnetii is readily transmitted between hosts and environmental reservoirs, a characteristic that is partially attributed to the ability of the bacterium to survive in the environment for long periods of time. The environmental stability of the organism seems to be linked to its ability to transition between distinct developmental stages. Small cell variants (SCVs) are metabolically inactive and resistant to numerous harsh environmental conditions. The switch from SCV to large cell variant (LCV) occurs after the invasion of host cells and during acidification of the phagosome, which triggers C. burnetii to become metabolically active 6, 7 . Until recently, the only characterized virulence factor of C. burnetii was lipopolysaccharide (LPS), which was identified through the observation that serial passage in a non-immunologically competent host results in the transition from a smooth to a rough phenotype and the loss of virulence 8 . Virulent smooth cell variants contain LPS with a complete O antigen and are referred to as phase I organisms, whereas avirulent rough cell variants lack the terminal O antigen sugars and are referred to as phase II organisms. The identification and characterization of other virulence factors has been facilitated by two recent advances: the development of axenic culture media and improvements in the tools available for genetic manipulation (BOX 3) .
In this Review, we describe our current understanding of the molecular pathogenesis of C. burnetii, including a discussion of a newly identified virulence factor, the type IV Dot/Icm (defect in organelle trafficking/intracellular multiplication) secretion system. We also describe how advances in extracellular cultivation techniques, genetic modification of clonal populations and the use of animal models of acute disease are helping to further our understanding of this intracellular pathogen.
The Coxiella burnetii infection cycle Adhesion and invasion. After aerosol transmission, C. burnetii targets alveolar macrophages and passively enters these cells by actin-dependent phagocytosis 9, 10 . The identification of a type IV secretion system (T4SS) in C. burnetii suggested that this bacterium uses an active trigger mechanism (mediated by the secretion of T4SS effector proteins) to induce uptake after initial binding
Category B select agent
An infectious disease agent of the second highest priority, as defined by the US CDC guidelines for potential misuse. These agents are usually readily transmitted by aerosol, are stable in the environment and cause moderate morbidity and low mortality.
BL3 containment
A level of biocontainment that includes a separation from general traffic areas by double doors, airlocks and negative air flow. Access is limited to trained personnel and requires users to wear personal protective equipment. All research activities with potential exposure of the agent to the atmosphere are conducted within biosafety cabinets.
mutants have revealed that these bacteria have no defect in their ability to invade either phagocytic cells (monocytes and macrophages) or non-phagocytic cells, supporting the idea that entry into phagocytic cells proceeds via passive actin-dependent phagocytosis and that entry into non-professional phagocytes proceeds via an active zipper mechanism 12, 13 . Non-phagocytic cells do not usually engulf large particles; however, intra cellular pathogens can invade these cells after direct contact through the zippering of bacterial ligands to host cell receptors.
Virulent C. burnetii binds to phagocytic cells using α V β 3 integrin as the main receptor and enters the cell via RAC1-dependent phagocytosis, which requires membrane ruffling 14, 15 (FIG. 1) . Interestingly, α V β 3 integrin is typically involved in the removal of apoptotic cells via phagocytosis, and this is generally associated with an inhibition of inflammation 16 . Thus, the ability to use α V β 3 integrin for invasion might be exploited by C. burnetii as a mechanism to avoid the induction of an inflammatory response. Consistent with this, C. bur netii is characterized as a stealth pathogen that enters cells without alerting the immune system. Although the identity of the bacterial ligand for α V β 3 integrin has not been determined, a class of likely candidates would be membrane-associated proteins that contain the integrinbinding domain arginine-glycine-aspartic acid (RGD) 11 . α V β 3 integrin is poorly expressed on resting monocytes, so it is likely that C. burnetii uses other receptors to invade these cells 17 .
Although the identity of the receptor on nonprofessional phagocytes is currently unknown, the mechanism of C. burnetii entry into these cells also appears to be dependent on actin rearrangement 9 . As the β 3 -subunit is poorly expressed on bronchial epithelium, it seems unlikely that α V β 3 integrin is the primary receptor for uptake in non-professional phagocytes, assuming that invasion of non-professional phagocytic cells is an important component of respiratory infection 18 . Histopathological analysis was carried out on the lungs of both animal models of pneumonia and human patients with atypical pneumonia caused by C. burnetii, and this analysis identified monocytes and macrophages as the primary infection sites, but epithelial and endothelial cell infection was also evident 19 . In a variety of tissue culture models, including mouse fibroblasts (L929), African green monkey kidney cells (Vero), human monocytes (THP-1) and mouse macrophages (J774), C. burnetii cells of different phases exhibit distinct uptake kinetics, whereby avirulent phase II bacteria are more readily internalized than fully virulent phase I bacteria 9, 10 . Although this is an interesting phenomenon, the mechanisms by which these variants enter host cells is not discussed in depth here, as phase II C. burnetii does not cause infections in immunocompetent animal models or humans 20 . However, both phase I and phase II C. burnetii replicate with similar kinetics and in indistinguishable, proteolytically active CCVs in tissue culture cells 21 , which is important to note because many studies that examine intracellular trafficking (see below) have used the avirulent phase II variant (as it requires only BL2 containment) 22 . Both phase I and phase II variants engage the α v β 3 integrin receptor in monocytes, but dramatic reorganization of the filamentous (F)-actin cytoskeleton is observed with phase I bacteria only 14 . Cytoskeletal changes during invasion are a common effect of several other invasive pathogens that promote phago cytosis through the secretion of effectors which activate host GTPases 23, 24 . Although the T4SS of C. burnetii is not required for uptake by the host cell, it remains to be determined whether T4SS effectors contribute to the reorganization of the actin cytoskeleton during infection 12, 13 . Interestingly, actin-cytoskeletal ruffling induced via SRC tyrosine kinases is observed following the binding of phase I C. burnetii 25 . This membrane ruffling requires contact between C. burnetii and host cells and can be induced using purified LPS from phase I bacteria 25, 26 . The ability to induce these ruffles is also dependent on the expression of Toll-like receptor 4 (TLR4) on the host cell surface 27 . These observations suggest that LPS induces membrane ruffling and the T4SS effectors temporally control downstream signalling cascades after internalization, although this has not yet been demonstrated experimentally.
Box 1 | Clinical presentation and epidemiology of Q fever
Q fever is a zoonosis that is most often transmitted by aerosolized soil or animal products contaminated with Coxiella burnetii. Cattle, sheep and goats are the most common reservoirs for this pathogen, but it also infects many wild animal species and arthropods, and is therefore considered a ubiquitous zoonotic contaminant 107 . Although infection rarely results in mortality, it does cause significant morbidity. Furthermore, the bacterium is stable for long periods in the environment and has therefore been classified as a category B select agent by the US CDC because of the potential for use as a bioterrorism agent 108 . The infectious dose for C. burnetii can be as low as a single organism in the lungs, and acute Q fever usually occurs 2-6 weeks after exposure, although the infection remains asymptomatic in >50% of cases. Symptomatic disease is characterized by high fever, severe headache (retro-orbital), myalgia, malaise, pneumonia and hepatitis, and usually lasts 1-2 weeks 109 . In symptomatic cases, the acute illness spontaneously resolves within 1-6 weeks and is effectively mitigated by antibiotics such as tetracycline and third-generation cephalosporins 110, 111 . By contrast, some studies have estimated that in 1-2% of cases, acute Q fever develops into a chronic infection that manifests as endocarditis, hepatitis or as an incompletely defined post-Q fever fatigue syndrome [112] [113] [114] . Diagnosis of acute Q fever is difficult because obtaining a culture of the organism is challenging and requires a BL3 containment laboratory. Diagnosis relies on serology using immunofluorescence assays and ELISAs (enzyme-linked immunosorbent assays).
Most outbreaks involve a limited number of people, but the potential impact on a large population was recently highlighted by infections in the Netherlands 115 . Between 2007 and 2010, more than 4,000 cases of acute Q fever were reported in this country, with an annual summer seasonal peak. The outbreak was mainly restricted to the south of the country, coincident with intensive dairy goat farming in this region, and the source of the infections seemed to be linked to several goat herds in close proximity to population centres. The outbreaks provided a clear demonstration of the threat to public health if adequate diagnostic, therapeutic and epidemiological tools are not developed and available. Following the introduction of veterinary control measures in 2009 (including the vaccination of goat and sheep dairy herds, culling of pregnant animals on infected farms 116 and improved hygiene procedures), the number of reported Q fever cases in the Netherlands has returned to the low historical rates (fewer than ten cases per year). In addition, a dramatically improved diagnostics and epidemiology network is now established, and public health officials are anticipating a slow influx of chronic disease cases over the next decade, as a result of the ~15% infection rate estimated for the regional populations in which the outbreaks occurred 117 .
Integrin
A highly conserved family of heterodimeric surface glycoproteins involved in binding to extracellular matrix components such as fibronectin and vitronectin through arginine-glycine-aspartic acid (RGD) domains.
BL2 containment
A level of biocontainment that involves the use of standard laboratory space in which work using an infectious agent is carried out within a biosafety cabinet.
SRC tyrosine kinases
A family of kinases that was originally identified through homology to Rous sarcoma virus oncogene v-src and is involved in signal transduction from cellular receptors.
Cachexia
Loss of weight, fatigue and weakness that are associated with severe inflammatory disease and cannot be reversed by nutritional supplementation.
From phagosome to CCV. Phagocytosis results in the formation of the phagosome, which matures into a phagolysosome following a series of highly ordered and regulated fusion and fission events 1 . Shortly after internal ization at the cell surface, the nascent phagosome develops into an early phagosome and acquires the small GTPase RAB5. This GTPase stimulates fusion with early endosomes, resulting in acidification of the lumen to approximately pH 5.4 (through an incompletely defined process) and acquisition of the early-endosomal marker protein EEA1 (REF. 28 ). One of the most striking features of the maturing phagosome is that its size remains constant, indicating that membrane components are constantly removed after fusion events 1 . The late phagosome lacks RAB5 but acquires the GTPase RAB7, lysosome-associated membrane glycoprotein 1 (LAMP1), LAMP2 and the vacuolar ATPase, which pumps protons into the maturing phagosome to further decrease the lumenal pH to about pH 5 (REF. 28 ). Finally the phagosome fuses with lysosomal compartments to acquire cathepsins and hydrolases, and the vacuolar ATPase further reduces the pH to around pH 4.5
The maturation of the CCV essentially follows the canonical endosomal pathway described above, but there are a number of important differences that rely on specific bacterial proteins. Thus, these differences are considered pathogenic mechanisms, although how they benefit C. burnetii remains to be determined. After internal ization of the bacterium, the nascent CCV is similar in size to a nascent phagosome and sequentially recruits RAB5 and RAB7, indicating that it traffics through the typical endosomal cascade described above 22 ( FIG. 1) . However, maturation of the CCV involves expansion of this compartment to a size that almost completely fills the host cell cytoplasm, an aspect that differs vastly from the unchanging size of the maturing phagolysosome 1, 29 (FIG. 1) . Simultaneous functional inhibition of
Box 2 | Pathotype-specific virulence
Pathotype-specific virulence of Coxiella burnetii is a long-standing hypothesis that could account for the difference between the propensity of different isolates to cause either acute or chronic disease [118] [119] [120] [121] [122] . Restriction fragment-length polymorphism (RFLP) and pulse-field gel electrophoresis (PFGE) analysis of DNA isolated from 32 C. burnetii strains led to the differentiation of isolates into six genomic groups (group I to group VI; see the table (group III is not shown)) 119 that showed a distinct pattern of association with acute and chronic disease. Interestingly, isolates from group I, II and III are associated with acute infections, whereas groups IV and V consist of isolates associated with chronic infections (group VI contains the C. burnetii str. Dugway isolates, which have low virulence in guinea pigs). Other genotyping approaches have taken advantage of the fully sequenced C. burnetii genome using either multispacer sequence typing (MST) or multiple-locus variable number of tandem repeats analysis (MLVA). MST analysis suggested that the plasmids QpH1 and QpDV are associated with acute disease isolates, and QpRS is associated with chronic disease isolates, indicating a correlation between genotype and disease manifestation 118 . Similarly to MST analysis, MLVA analysis demonstrated that there are genetic differences between isolate groups from acute and chronic disease, suggesting that isolates cluster into distinct groups according to disease severity 118, 121 . Consistent with this, there are no polymorphic ORFs between the isolates in restriction group I and the reference isolate C. burnetii str. RSA 493 (also in group I), but 87 polymorphic ORFs were identified between group V isolates and C. burnetii str. RSA 493, and at least half of these were annotated as hypothetical proteins 123 . These results are intriguing because isolates from group V are associated with chronic infections, suggesting that novel virulence factors contribute to distinct acute and chronic pathotypes 119 .
In a mouse infection model, isolates from group I induce persistent high-level cytokine secretion throughout the duration of infection, whereas group IV and group V isolates induce only moderate secretion at the peak of clinical disease 124 . In the guinea pig model, isolates from group IV fail to induce fever, whereas group I isolates induce high fever and cause death at the highest challenge dose. In the severe combined immunodeficiency (SCID) mouse, which cannot mount an acquired immune response, group I isolates cause severe cachexia and death, whereas group IV and group V isolates induced only transient weight loss. Although this evidence clearly suggests that genetic pathotype differences exist, host factors are also likely to be involved in the development of chronic Q fever, as patients who develop a chronic infection often exhibit elevated interleukin-10 (IL-10) production 125 , and mice that constitutively express IL-10 have been proposed as a suitable chronic model for Q fever 126 . It is likely that both pathotype-specific differences and host factors are involved in the development of chronic Q fever. 
Isolate (strain name)

Himar1-based transposon system
A eukaryotic horn fly element that is extensively used to create mutations in bacteria and relies on only an AT dinucleotide for insertion.
both RAB5 and RAB7 through dominant-negative mutations impairs expansion of the CCV, whereas inhibition of RAB5 alone (but not RAB7 alone) blocks C. burnetii entry into host cells 22 . Furthermore, formation of the large CCV is dependent on active C. burnetii protein synthesis, probably because of a requirement for the synthesis and subsequent secretion of effectors across the CCV membrane into the cytoplasm 5, 12 . However, in the absence of protein synthesis, small CCVs still acquire LAMP proteins and acidify, suggesting that the acquisition of LAMPs and acidification are passive processes, similar to the normal maturation process of phagosomes 30 . Most intracellular pathogens subvert the endosomal cascade and arrest maturation of the phagosome at an early stage to avoid fusion with lysosomes 2 . However, in C. burnetii, lysosomal enzymes, including cathepsin D (CTSD) and lysosomal acid phosphatase (ACP2), accumulate in the CCV, although this is delayed until 2 hours after infection (compared with only 15 minutes after infection for phagosomes harbouring inert particles) 4 . It has been suggested that the delay is caused by interactions of the CCV with the autophagy pathway 22 . The T4SS of C. burnetii is unlikely to be involved, as translocation of effectors does not occur until at least 8 hours after infection, suggesting that the bacterial proteins which interact with the autophagy pathway remain to be identified 13 . Autophagy is implicated in host defence through innate and adaptive immunity to intracellular pathogens 31 , and as early as 5 minutes after internalization, the CCV is decorated with the autophagy marker microtubule-associated protein light-chain 3 (LC3) 3, 22 (FIG. 1) . However, the role of autophagy in C. burnetii pathogenesis is unclear; a recent genome-wide RNAi screen failed to show that autophagy is essential for C. burnetii growth. On the other hand, if autophagy is induced in the host cell before infection with C. burnetii, the intracellular bacterial load and the size of the CCV increase 32, 33 . One potential benefit of the autophagy interaction is that autophagy vesicles are often loaded with nutrients and membranes from their degraded cargo, and these components might serve as fuel for the SCV-to-LCV conversion 22, 32 . The conversion to LCVs coincides with the arrest of CCV endosomal maturation; the percentage of LCVs (as a proportion of the total number of SCVs and LCVs) 1 hour after infection approaches 80%, and by 16 hours the CCV contains only LCVs Between 8 hours and 2 days after infection, the CCV enlarges drastically and can occupy nearly the entire volume of the host cell 34 . The large CCV forms as a result of homotypic fusion of multiple smaller CCVs, and it can continue to expand through heterotypic fusion with autophagic, endocytic and lysosome vesicles 5, 30 . Maintenance of the large CCV not only requires protein production by the bacterium 30 , but also depends on the actin cytoskeleton, as treatment of infected cells with actin-depolymerizing agents results in the formation of small CCVs only 35 . In addition, C. burnetii infection activates the host cell kinase families protein kinase C, protein kinase A and myosin light chain kinase, which are required for the establishment and maintenance of the CCV 36 . Furthermore, during this stage of the infection, the CCV interacts with the early secretory pathway (as suggested by the accumulation of RAB1B on the CCV membrane), an interaction which is required for formation of the large CCV 37 (FIG. 1) . Interaction with the ER through the early secretory pathway might provide a source of lipids for the formation of the large CCV. These interactions are probably orchestrated by C. burnetii effectors, as bacterial protein production is required for the formation of the large CCV; however, the identity and specific functions of these putative effectors remain to be determined 37 . Interestingly, the CCV membrane contains a comparable amount of cholesterol to that in the plasma membrane, which is twice that of a normal lysosomal compartment 38 . Furthermore, host genes involved in cholesterol synthesis are upregulated during C. burnetii infection, and inhibition of cholesterol metabo lism Box 3 | Recent progress in the development of extracellular growth media and genetic tools
The first successful introduction of exogenous plasmid DNA into Coxiella burnetii was reported more than 10 years ago and involved the transformation of eukaryotic host cell-propagated C. burnetii with a shuttle vector containing a 5.8 kb autonomous replication sequence (ARS) 127, 128 . The generation of new genetic tools has benefited from the development of axenic media to propagate C. burnetii. This advance was made after a breakthrough metabolic study demonstrated that the organism has enhanced metabolic potential in vitro in the presence of acid activation buffer (pH 4.5) 129 . The second major breakthrough came after the discovery that terminal oxidases are associated with micro-aerophilic respiration 130 . This led investigators to test the metabolic potential of C. burnetii at low oxygen levels, which revealed that 2.5% oxygen is optimal for growth and metabolism 130 . In turn, these two observations led to the development of acidified citrate cysteine medium (ACCM), which allows for an ~3 log increase in the number of genome copies after 6 days of culture 130 . Shortly after the development of ACCM, genetic transformation and the isolation of single colonies on solid medium were achieved using an improved medium (ACCM-2) 75 . The ability to isolate single colonies allowed the Himar1-based transposon system to be used for the generation of mutant libraries 131 . The original C. burnetii Himar1 mutants were isolated after electroporation and infection of Vero cells, a technical and laborious process 131 . A second important genetic tool was a stably maintained shuttle vector plasmid for C. burnetii containing the plasmid RSF1010 origin of replication (adapted from use in Legionella pneumophila) 127 . As an alternative approach to transformation with plasmids, a site-specific Tn7 transposition system was recently developed 132 . Finally, an easy-to-use, site-directed mutagenesis strategy has now been developed, which will accelerate the testing of virulence gene candidates in C. burnetii mutants 64 . This complement of genetic tools and extracellular growth methods will now allow for the fulfilment of Koch's postulates to verify the functions of a number of genes, including the candidate virulence factor genes. Maturing CCV ∼pH 5 α v β 3 Nature Reviews | Microbiology negatively affects CCV formation, suggesting that C. burnetii directly influences cholesterol metabolism, potentially through interactions with the ER [38] [39] [40] . Although these events are reasonably well characterized, the C. burnetii virulence factors that direct formation of the CCV remain to be identified.
Mature CCV. Approximately 6 days after infection, the CCV is heavily loaded with LCV bacteria, which start differentiating back into SCVs 6 (FIG. 1) . The mature CCV maintains essentially the same features as the early CCV: the pH remains low (it has a pH of about 4.5-5, the same pH as the phagolysosome in uninfected cells 41 ) and the vacuole contains all of the same markers. In addition, the mature CCV retains fusogenic capacity, which relies on C. burnetii protein synthesis 5 . Surprisingly, host cell viability is not affected by the drastic expansion of the CCV, which occupies much of the cytoplasm and with a volume much larger than the space required by C. burnetii 42 . In addition, the generation time and genome stability of the host cell is unchanged 43 . C. bur netii prolongs host cell viability in two ways: it actively inhibits apop totic signalling pathways, and it induces pro-survival factors. For example, C. burnetii prevents the induction of apoptosis following exogenous activation with the pro-apototic drug staurosporine, and this inhibitory effect is dependent on protein production by the bacterium 42 . The anti-apoptotic activity of C. burnetii could be the result of the interplay between beclin 1 (BECN1) and BCL2. BECN1 is an autophagy initiation protein that interacts with the anti-apoptotic protein BCL2, and both are present on the CCV. Their interaction prevents the release of cytochrome c from the mitochondria and thereby , which is characteristic of normal phagosomal development. By contrast to phagosomes, the CCV also acquires microtubule-associated protein light-chain 3 (LC3; an autophagosomal marker), a process that is dependent on bacterial protein synthesis. The nascent CCV develops through fusion and fission events with early endosomes and then late endosomes, leading to the disappearance of RAB5 and EEA1 and the acquisition of RAB7 and lysosome-associated membrane glycoprotein 1 (LAMP1) 40 to 60 minutes after internalization, in concurrence with a further acidification to pH 5, which is characteristic of normal phagosomal development. Lysosomal enzymes, including cathepsin D (CTSD), start accumulating in the CCV by 2 hours after internalization, at which point the vacuole is at ~pH 4.5; this is delayed significantly from normal phagolysosomal acquisition of CTSD. This pause in CCV development might allow conversion of the bacteria from small cell variants (SCVs) to the metabolically active large cell variants (LCVs). Between 8 hours and 2 days after internalization, the CCV expands to occupy an increasingly dominant portion of the cytoplasmic space of the host cell. This process is dependent on bacterial protein synthesis and involves the recruitment of both RHO GTPase and RAB1B to the CCV membrane. RHO GTPase is likely to be involved in maintenance of the large vacuole, whereas the recruitment of RAB1B from the ER might facilitate the acquisition of additional membranes to create this spacious CCV.
C. burnetii str. Nine Mile I
The original Coxiella burnetii strain isolated from ticks in 1935. This strain was later serially passaged in embryonated hen eggs and guinea pigs to obtain the avirulent isolate C. burnetii str. Nine Mile II.
leads to apoptosis inhibition, a phenomenon associated with C. burnetii infection and a known function of BCL2 (REFS 44, 45) . A second anti-apoptotic activity initiated after C. burnetii infection is the sustained activation of the pro-survival signalling proteins ERK1 (also known as MAPK3), ERK2 (also known as MAPK1) and the AKT family 46 . Promoting the survival of infected cells seems to be essential for the establishment and maintenance of chronic C. burnetii infections. There is evidence to suggest that during host cell cytokinesis the large CCV is segregated to only one of the daughter cells, leaving the other cell uninfected 47 . This would provide the bacterium with host cells to infect, thereby promoting a chronic infection. The ability to prevent apoptosis and stimulate pro-survival pathways would also be beneficial for persistent infection, as this activity maintains the host cell to allow continued replication of the bacterium. During acute infection, the infectious dose can be as low as 1-10 C. burnetii cells, which suggests that there are other mechanisms in place that promote the spread of replicating bacteria to infect other susceptible cells 48 . A recent report demonstrated that C. burnetii is also able to induce apoptosis through the release of cytochrome c in a mechanism that is dependent on bacterial protein synthesis 49 . Therefore, the prevention of apoptosis seems to be exploited by C. burnetii to cause persistent infections, whereas induction of apoptosis seems to enable spread of the infection to nearby susceptible cells. This strategy is also used by other intracellular pathogens; for example, Mycobacterium tuberculosis inhibits apoptosis early during infection, but induces cell death at a later stage of infection 50 .
Dot/Icm secretion and host subversion
Sequencing of the C. burnetii genome identified three secretion systems: a type I secretion system (T1SS) 51 , a T2SS-related pilus biogenesis machinery 52 and a conjugation-related T4SS 53 . Currently, little is known about the role of the T1SS and T2SS in the pathogenesis of C. burnetii. By contrast, the availability of Legionella pneumo phila as a surrogate host for the expression of putative C. burnetii T4SS effectors has provided insight into the role of this secretion system, and this is the focus of the discussion below.
The T4BSS (the Dot/Icm secretion system). T4SSs translocate effector substrates from the bacterial cytosol directly into the cytosol of eukaryotic host cells and are intimately involved in the pathogenesis of many bacteria. These multicomponent protein machines can be sub divided into several substructures, including a pilus, a core transport complex and a type IV coupling protein complex 54 (FIG. 2) . Furthermore, T4SSs are separated into two subgroups, T4ASS and T4BSS, on the basis of homology to the Agrobacterium tume faciens and L. pneumo phila systems, respectively 55 . The T4BSS, which is also known as the Dot/Icm system, resembles the conjugation machinery encoded on IncI plasmids. Studies with L. pneumophila have identified several core complexes that define the topology of the Dot/Icm apparatus, such as the subcomplex consisting of DotC, DotD, DotF (also known as IcmG), DotG (also known as IcmE) and DotH (also known as IcmK), which bridges the inner and outer bacterial membranes and is functionally the core transport complex 56 (FIG. 2) .
A second subcomplex comprises the coupling protein DotL (also known as IcmO) (which recruits IcmSWdependent substrates to the secretion apparatus), DotM (also known as IcmP), DotN (also known as IcmJ), IcmS and IcmW 57 (FIG. 2) . The C. burnetii str. Nine Mile I isolate encodes homologues for 24 of the 27 Dot/Icm proteins found in L. pneumophila, and this high degree of similarity between the two systems suggests that they are structurally similar 11 . The C. burnetii genome lacks dotV (also known as icmC), icmR and dotJ (also known as icmM), but has a gene duplication of dotI (also known as icmL; resulting in the genes icmL.1 and icmL.2); the similarity of DotJ and DotI suggests that this DotI duplication can substitute for the absence of DotJ, a functional homologue of IcmR 11, 58 (FIG. 2) . The conservation between these two T4BSSs became apparent when it was shown that dotB, icmS, icmW and icmT from C. burnetii can complement the intracellular growth defect associated with an L. pneumophila strain in which these genes are mutated 59 . This was the first indication that C. burnetii encodes a functional Dot/Icm system and led to the use of L. pneumophila as a surrogate host to identify and characterize C. burnetii effector proteins 60, 61 (TABLE 1) .
Using this system, transcriptional analysis demonstrated that several C. burnetii dot/icm genes are actively transcribed at early time points after infection 62 , and similarly to in L. pneumophila, the Dot/Icm system localizes to the poles of C. burnetii cells during infection 63 . Using transposon and site-specific mutants, several studies have now confirmed the dependence of C. burnetii on the Dot/Icm system for intracellular survival 64, 12, 13 . Current research is now focused on identifying the roles of the T4SS effectors to provide insight into the pathogenic mechanisms of this intracellular bacterium.
Identification and characterization of Dot/Icm substrates.
Initially, all C. burnetii effector screens used L. pneumo phila as a surrogate host 65, 66 . However, the development of C. burnetii shuttle vectors (BOX 3) enabled the adaptation of fluorescence-based β-lactamase (TEM1) translocation assays for C. burnetii, which were used to confirm the results observed using L. pneumophila 61, 67 . Recent genetic and bioinformatic screens have identified 60 C. burnetii Dot/Icm substrates (the best characterized of which are shown in horizontal gene transfer from a eukaryotic source 51, 69 . Furthermore, similarly to L. pneumo phila effectors, many of the C. burnetii T4SS substrates contain a carboxyterminal motif or recognition sequence that is required for translocation 61, 66, 67 . Bacterial pathogens use the T4SS as part of their virulence programme to control the activity of various effector proteins in order to ensure the proper progression of infection. For example, the L. pneumophila effector protein LubX acts as an E3 ubiquitin ligase that targets the effector SidH for degradation several hours after infection, representing a mechanism of temporal control 70 . C. bur netii effector functions are likely to be controlled by similar temporal mechanisms, including transcriptional control, translocation efficiency and protein stability in host cells. This hypothesis was supported by the recent observation that C. burnetii Dot/Icm effectors are not translocated until 8 hours after infection and also require acidification of the CCV for translocation 13, 71 . Although this expression pattern is in agreement with the ability of dot/icm mutants to passively traffic through the endocytic pathway to the phagolysosome, it does not explain how C. burnetii is able to manipulate the autophagy pathway immediately after uptake into host cells, nor how the bacterium delays lysosomal fusion 12, 13 . Thus, it is possible that T4SS-independent effectors are involved in the manipulation of the autophagy pathway and the delay in lysosomal fusion.
Another mechanism of control is executed at the transcriptional level by the two-component regulatory system PmrAB, which has been shown to directly regulate the Dot/Icm secretion system in both L. pneumo phila and C. burnetii 72 . The PmrAB system regulates virulence genes in other pathogenic bacteria, such as Pseudomonas aeruginosa, in response to low Mg 2+ levels, high Fe 3+ levels and low pH 73 . Bioinformatic analysis revealed that genes encoding five of the structural Dot/Icm proteins (dotP (also known as icmD), icmQ, icmV, icmW and dotD) contain a PmrA-binding sequence located upstream of the -10 region of their promoters. Furthermore, 20 putative PmrA-regulated C. burnetii genes have been confirmed as Dot/Icm substrates, indicating that this system might represent a global virulence regulator in C. burnetii 61, 65, 72 . Bioinformatic analysis also suggests that other unknown mechanisms exist for regulating non-PmrA-regulated effectors, as many newly identified effectors do not contain PmrAbinding sequences but are still secreted. Although L. pneumophila and C. burnetii are phylo genetically related, only ten of the identified Dot/Icm substrates from C. burnetii display significant similarity to any of the >250 L. pneumo phila T4SS substrates. This is not surprising considering that L. pneumophila and C. bur netii replicate in distinct vacuolar compartments during co-infection 74 , and suggests that L. pneumophila and C. burnetii Dot/Icm effectors have specific functions Coxiella burnetii encodes 24 of the 27 Legionella pneumophila type IVB secretion system (T4BSS) components. The C. burnetii system lacks three homologues, DotJ (defect in organelle trafficking J; also known as IcmM), DotV and IcmR (intracellular multiplication R), which are depicted with a dashed outline. Studies using L. pneumophila identified a subcomplex termed the core transport complex, which links the inner and outer membranes and is composed of DotC, DotD, DotF, DotG and DotH. As this complex is also conserved in the T4ASS, it is hypothesized that C. burnetii assembles a similar complex. A second subcomplex consists of the coupling protein DotL (providing a link between the substrates and the transport complex), DotM, DotN, IcmS and IcmW. The ATPase activity of DotB is required for secretion, but the function of this activity remains to be determined. C. burnetii proteins that can substitute for the corresponding proteins in the L. pneumophila system are shown in maroon.
Insertion sequences
Mobile genetic elements consisting of short inverted repeats flanking one or more ORFs.
that target diverse vesicle trafficking pathways to create a distinct permissive replicative environment for each bacterium.
Plasticity and redundancy in Dot/Icm substrates from different pathotypes. The Dot/Icm effectors exhibit striking heterogeneity among the sequenced C. bur netii isolates belonging to different pathotypes 13 . Only 19 of the currently identified effectors, including three plasmid-encoded effectors, are fully conserved among the acute and chronic isolates (TABLE 1) . The fact that these effectors have been maintained in in all C. bur netii isolates suggests that they have essential roles for intracellular survival. The plasticity of the remaining effectors might be mediated, in part, by extensive recombination between abundant insertion sequences (ISs) found within the C. burnetii genome 51 . In isolates causing chronic and avirulent disease, the majority of homologues for the C. burnetii Nine Mile I effectors are either truncated or found as pseudogenes. This suggests that the truncated homologues are nonfunctional, a hypothesis supported by the observation that ectopic expression of CBU1532 (encoded by C. burnetii str. Nine Mile I) leads to rounding of the host cell, whereas the alternative-start homologue CBUD0454 (encoded by C. burnetii str. Dugway) does 
Ankyrin repeats
Eukaryotic protein domains consisting of repeating segments of 33 amino acids that form a helix-turn-helix motif and mediate proteinprotein interactions. These domains are some of the most commonly found domains in eukaryotic proteins.
Coiled-coil domains
Structural motifs that are found in proteins and consist of 2-5 α-helices wrapped around each other in a left-handed manner to form a superhelix.
Tetratricopeptide repeats
Structural motifs that mediate protein-protein interactions and are composed of a degenerate ∼34 amino acid sequence that is often arranged in a tandem array. not induce this phenotype 13 . Thus, we speculate that several group-specific Dot/Icm effectors participate in pathotype-specific virulence, a hypothesis that is now testable with site-specific mutagenesis methods 64, 75 . Compared with other secretion systems, the Dot/Icm system from L. pneumophila has an astounding number of substrates. Dot/Icm is capable of translocating at least 8.5% of the L. pneumophila proteome (which corresponds to approximately 250 out of 2,943 ORFs). Why would a pathogen need so many effectors? An intriguing recent study suggests that at least 30% of L. pneumophila Dot/Icm effectors are not involved in the establishment of mammalian infection, but have been acquired instead to enable adaptation to multiple hosts 76 . Although a survey of the C. burnetii proteome for secretion substrates is incomplete, it seems that a substantial proportion of the proteome -to date, 5.8% -does serve as T4SS substrates 13, 60, 61, 65, 67, 68 (Robert A. Heinzen, personal communication). C. burnetii is capable of infecting and colonizing a wide range of mammalian and arthropod hosts, and a diverse pool of T4SS substrates might facilitate this wide host range. In addition, L. pneumophila encodes several examples of multiple effectors that target the same host pathway to orchestrate intracellular bacterial survival. Evidence suggests that C. burnetii uses a similar strategy, as three effectors have been identified that inhibit apoptosis (AnkG, CaeA and CaeB) 77, 78 (TABLE 1) .
F-box domains
Diverse cytosolic functions for Dot/Icm effectors. The majority of the identified Dot/Icm substrates are annotated as hypothetical proteins. However, most encode one or more eukaryotic-like domains implicated in proteinprotein interactions, and these domains provide clues to protein functionality. These domains include ankyrin repeats, coiled-coil domains and tetratricopeptide repeats 13, 61, 66 (TABLE 1). Other substrates have eukaryotic-like domains that are implicated in post-translational modifications, such as putative serine/threonine kinase domains, F-box domains and Fic domains 13, 61, 67 (TABLE 1) . Eukaryotic proteins carrying these motifs are involved in a variety of host processes, including apoptosis, ubiquit ylation, lipid metabolism and membrane trafficking, suggesting that C. burnetii effectors are involved in modulating many of these cellular processes 65, [79] [80] [81] [82] [83] . For example, the T4SS effectors AnkG, CaeA and CaeB all prevent intrinsic apoptosis 77, 78 ( FIG. 3; TABLE 1 ). Modulation of apoptosis by AnkG is dependent on the ability of AnkG to bind the host mitochondrial matrix protein p32 (also known as C1QBP); the mechanism of action of p32 during apoptosis has not yet been established, but the protein is thought to regulate the opening of the permeability transition pore 78 . CaeB localizes to the mitochondria and inhibits mitochondrial membrane permeabilization, thus preventing the release of pro-apoptotic proteins 77 (FIG. 3) . These two effectors target the same cellular pathway, albeit through different mechanisms. Although CaeA localizes to the nucleus, the exact mechanism of apoptosis inhibition by this protein remains to be determined 77 . As discussed above, for C. burnetii, the benefits of inhibiting apoptosis include the maintenance of host cell viability, despite the mature CCV occupying almost the entire volume of the cell.
Functional assays serve as a starting point for characterizing the many effector functions of C. burnetii, and ectopic expression of effector proteins in eukaryotic cells has demonstrated that many effectors target specific host organelles 13, 61, 66, 67 . For example, at least three effectors (CaeA, CBU1314 and CBU1976) are targeted to the nucleus 13, 61 , and this probably depends on the presence of nuclear localization motifs (TABLE 1) . As C. burnetii infection has been shown to alter host gene transcription 84 , it is reasonable to suggest that these putative nuclear effectors are involved in this process (FIG. 3) . In addition, several vesicle-associated effectors target the CCV and autophagosome compartments 13, 66 . Recently, researchers have identified a family of CCV-binding proteins, several of which are essential for intracellular replication (Robert A. Heinzen, personal communication). These effectors might serve as CCV stabilizers or as docking points for signalling molecules, and/or they might promote the fusogenic activities of the CCV (FIG. 3) . Because C. burnetii alters the fusogenic capacity of the CCV, identi fying effectors that disturb the secretory pathway in eukaryotic cells is crucial. C. burnetii actively modulates vesicle trafficking pathways by recruiting membranes to the CCV, and there is evidence that the early secretory pathway contributes to CCV biogenesis 37 . Dot/Icm effectors that interfere with the host secretory pathway have been identified for L. pneumophila using a SEAP (secreted embryonic alkaline phosphatase) assay 65, [85] [86] [87] . In C. burnetii, an effector (CBU0635) that disrupts mammalian secretory pathways has been identified using the same assay and localizes next to the Golgi apparatus 13 (FIG. 3; TABLE 1 ). Further analysis will be required to determine the mechanism of action of CBU0635 and its contribution to C. burnetii virulence.
Ubiquitin-related F-box-containing proteins represent an interesting group of Dot/Icm effectors. Similarly to L. pneumophila, C. burnetii encodes several paralogues of F-box-containing proteins; three of them have been confirmed to be Dot/Icm effectors, and one (CpeC) is associated with ubiquitin 61, 67 . On the basis of their function in eukaryotic cells, this group of proteins might promote proteasome-mediated protein degradation 70, 88 . For example, AnkB (an F-box protein) of L. pneumophila targets non-essential host proteins (through ubiquitylation) for degradation by the 26S proteasome, providing a source of amino acids for bacterial growth 88 . A second possible mechanism involves the degradation of host proteins that impede bacterial replication. Whether C. burnetii F-box proteins have similar roles remains to be determined.
Our knowledge of the functions of the Dot/Icm effectors from C. burnetii is still in its infancy. However, the recent description of a site-directed mutagenesis system for C. burnetii 64 should aid in the characterization of all ~120 identified effectors and help to establish how they contribute to pathogenesis.
Immune evasion strategies C. burnetii has several immune evasion strategies that are associated with the structure of its LPS. Virulent phase I C. burnetii produces LPS with a complete O antigen and exhibits serum resistance (the bacterium only moderately activates complement and prevents surface deposition of complement factor C3b) 89 . Furthermore, the structure of this so-called smooth LPS masks bacterial recognition by the pattern recognition receptor TLR2 (REF. 90 ), which recognizes ligands within LPS. By contrast, avirulent phase II C. burnetii produces a rough LPS, which lacks the terminal O antigen sugars and is readily detected by TLR2; this detection induces the production of inter leukin-12 (IL-12) and tumour necrosis factor (TNF), and activates macrophages to mediate bacterial clearance 91 . Conversely, phase I C. burnetii does not induce maturation of primary dendritic cells (DCs) and induces the production of relatively low levels of IL-12 and TNF 90 . This suggests that the LPS of phase I bacteria, containing the full-length O antigen, shields TLR2 ligands on the bacterial cell surface 90 . Other studies have shown that LPS from both phase I and phase II C. burnetii induces the production of TNF in macrophages, but this induction is likely to be due to contaminating TLR2 ligands, as purified LPS (which could contain contaminating TLR ligands) but not chromatography-purified lipid A (the LPS component recognized by TLR4) induces TLR2 signalling 15, 91, 92 . Early studies showed that C. burnetii LPS is ~1,000-fold less endotoxic than the LPS from enteric species such as Escherichia coli 93 . It was subsequently discovered that C. burnetii uses a second LPS-dependent intrinsic immune evasion strategy: rather than serving as an agonist of TLR4 signalling, C. burnetii lipid A acts as a TLR4 antagonist 91 . The lipid A portion of C. burnetii LPS (both phase I and phase II variants) is composed of a tetra-acylated structure, a form of lipid A that is associated with antagonism of TLR4 signalling in several other bacterial pathogens, including Yersinia pestis [94] [95] [96] . Elucidating the role of TLR4 in C. burnetii pathogenesis was complicated by the observation that this cell surface receptor seems to be involved in actin rearrangement and phagocytosis of virulent phase I C. burnetii 27 . However, studies suggest that the ability of TLR4 to distinguish between the LPS of phase I and phase II Figure 3 | Roles of type IV secretion system effectors during Coxiella burnetii intracellular infection. A new family of type IV secretion system (T4SS) effectors has been identified that localizes to the Coxiella-containing vacuole (CCV) and might have diverse functions, such as CCV stability and fusogenicity. Located next to the Golgi apparatus, CBU0635 interferes with the host secretory pathway on ectopic expression. At least three T4SS effectors localize to the nucleus (CaeA, CBU1314 and CBU1976) when ectopically expressed in host cells, and these proteins might be involved in the transcriptional modulation that occurs during Coxiella burnetii infection. Exogenously stimulated apoptosis is modulated by C. burnetii, and an ankyrin repeat-containing protein (AnkG) has anti-apoptotic activity through an interaction with p32, a host protein that is involved in pathogen-induced apoptosis. A second T4SS effector, CaeB, alters mitochondrial membrane permeability during exogenously stimulated apoptosis. C. burnetii infection also increases the synthesis of anti-apoptotic proteins BCL2-related protein A1 (BCL2A1; also known as BFL1) and cIAP2 (also known as BIRC3) and causes activation of the pro-survival kinases AKT, ERK1 and ERK2. Other effectors might also be involved in the modulation of apoptosis. Several T4SS effectors have F-box domains and are potentially involved in promoting proteasome-mediated degradation of proteins; these effectors include CpeC, which localizes to ubiquitin-rich compartments in host cells. The effector CpeB has been localized to the autophagosome, and AnkA, AnkB and AnkF localize to the cytoplasm. Dashed arrows represent predicted effector functions that have not yet been experimentally demonstrated. All T4SS effectors are shown as green circles. BECN1, beclin 1; LCV, large cell variant; PKA, protein kinase A; SCV, small cell variant.
variants is not dependent on the structure of lipid A, but depends on novel signalling mechanisms involving O antigen-mediated phagocytosis (the O antigen is not present in phase II LPS) 27, 91 . Further studies will be required to resolve these findings, especially because the transcriptional profiles of host cells infected with either phase I or phase II C. burnetii do not show expression of genes required for TLR4 signalling 97 .
The ability of C. burnetii to evade detection by pathogen recognition receptors prevents the activation of infected macrophages and provides a replicationpermissive intracellular niche. A number of studies have shown that the activation of infected cells via interferon-γ (IFNγ) inhibits C. burnetii replication [98] [99] [100] [101] owing primarily to the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) 102 . C. burnetii prevents the production of ROS via the secretion of an acid phosphatase (CBU0335); the mechanism of action has yet to be confirmed, but it is likely that this protein prevents assembly of the NADPH oxidase complex, although this mechanism would be insufficient to protect against the high level of ROS that is induced by IFNγ 103, 104 . RNS production requires de novo synthesis of inducible nitric oxide synthase (iNOS), which occurs after the induction of pro-inflammatory cytokines such as those produced after TLR stimulation 105 . Indeed, in contrast to E. coli LPS, which stimulates macrophages to secrete nitrates, exposure of macrophages to C. burnetii does not lead to nitrate secretion, which is not surprising considering that C. burnetii invades cells without stimulating TLRs 97 . Host cell death is often induced after infection as an immune defence mechanism 50 . This serves two purposes: it eliminates the infected cell, and it allows the infected apoptotic blebs to be engulfed by DCs and the subsequent presentation of antigens through major histocompatibility complex (MHC) class I molecules, which induces protective immunity to intracellular patho gens 50 . Thus, the ability of C. burnetii to inhibit apoptosis represents an immune evasion strategy. Autophagy is another mechanism used by the innate immune system to remove intracellular pathogens. However, as mentioned above, C. burnetii actively recruits autophagy components to the CCV, and the induction of autophagy actually promotes C. burnetii intracellular replication 3, 32, 106 .
Conclusions
C. burnetii is ubiquitous in the environment, has a wide host range and has the potential to cause epidemic outbreaks, owing in part to its aerosol transmission and extreme stability. Thus, understanding the pathogenic mechanisms of this organism is a high research priority. From our understanding of the intracellular trafficking pathway and the host processes that are activated or suppressed during infection, it is clear that C. burnetii has adapted to a low-pH CCV and inhibits activation of its primary host cells, macrophages, by evading recognition by the innate immune system.
Research on C. burnetii is currently undergoing a renaissance. The long-standing idea that LPS is the sole virulence determinant is now considered invalid, and there is a growing appreciation for the essential role of a functional T4SS to promote intracellular growth. The C. burnetii T4SS transports more than 100 established substrates, but those that are essential for intracellular replication remain to be determined. Recent reports suggest that, compared with L. pneumophila, C. burnetii has several essential effectors that are secreted via the T4SS, demonstrating that there is less redundancy in C. bur netii than in L. pneumophila. High-throughput screening of random and defined mutant libraries is ongoing and will surely identify the next series of essential genes for intracellular growth in vitro and in vivo. Finally, the development of site-specific mutagenesis methods now allows the roles of predicted pathways and factors to be validated in order to gain an increasingly refined understanding of the molecular pathogenesis of Q fever.
